Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion type Assertion NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_head.
- NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion description "[Furthermore, methylation-dependent silencing of SOX11 has been reported for B cell lymphomas and indicates that epigenetic drugs may be used to re-express this tumour suppressor, but information on SOX11 promoter methylation in EOC is still lacking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_provenance.
- NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion evidence source_evidence_literature NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_provenance.
- NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion SIO_000772 21943380 NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_provenance.
- NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion wasDerivedFrom befree-2016 NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_provenance.
- NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_assertion wasGeneratedBy ECO_0000203 NP926015.RAefSBgqSCqkm9TPtlCQ5vh4TZ_jRiz7gCFcb2t6uDYV4130_provenance.